Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-IL-17A antibodies and their use in treating autoimmune and inflammatory disorders

Anti-IL-17A antibodies and their use in treating autoimmune and inflammatory disorders

US Patent 10683349 · Granted Jun 16, 2020

Estimated economic value: $32,015,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of cancer using a CD33 chimeric antigen receptor2025
Solubilized apyrases, methods and use2025
Pharmaceutical product container2024
Anti-IL-17A antibodies and their use in treating autoimmune and inflammatory dis2024
Anti-IL-17A antibodies and their use in treating autoimmune and inflammatory dis2024
Anti-IL-17A antibodies and their use in treating autoimmune and inflammatory dis2024
CKIT antibody drug conjugates2023
Phosphoglycerate kinase 1 (PGK) promoters and methods of use for expressing chim2022
Method of detecting TIM-3 using antibody molecules to TIM-32021
IL-18 binding molecules2021
3′ end caps for RNAi agents for use in RNA interference2021
Antibody molecules to TIM-3 and uses thereof2021